The Solv Foundation has announced the launch of its architecture on Stellar, a blockchain renowned for its speed and scalability.The Solv Foundation has announced the launch of its architecture on Stellar, a blockchain renowned for its speed and scalability.

Solv Foundation lands on Stellar: revolution in yield for 200 million USDC

stellar solv foundation

The Solv Foundation, a leader in the Bitcoin Finance sector, has announced the launch of its architecture on Stellar, the blockchain recognized for its speed, scalability, and dedication to financial services. 

This integration marks a turning point for the world of stablecoins, particularly for the 200 million USDC currently in circulation on Stellar, paving the way for new yield opportunities for both institutional and retail users.

From Payment Adoption to Asset Performance

USDC, already widely adopted on Stellar thanks to its accessibility in over 170 countries, has solidified its role as a benchmark asset for international payments, remittances, B2B transactions, and salaries. However, the growing demand from institutions and users for tools that allow them to leverage idle balances has prompted Solv Foundation to step in with innovative solutions.

As highlighted by Ryan Chow, co-founder and CEO of Solv:

Solv Foundation: the platform that transforms stablecoins

Solv Foundation positions itself as a strategic layer that transforms stablecoins from mere payment tools into productive, yield-bearing assets. Through solutions like the BTC+ vault, institutional lending, and capital-efficient looping strategies, Solv enables fintech, SMEs, remittance operators, and retail users to convert liquidity intended for payments into tangible yield. In this way, USDC evolves from a simple settlement currency to a true on-chain market asset.

A Global Distribution Ecosystem

The expansion of Solv on Stellar is bolstered by the blockchain’s extensive distribution network, which includes global partners such as Circle, PayPal, MoneyGram, and a range of regional wallets and fintechs including Airtm, OwlPay, ChipperCash, Meru, Yellow Card, Mercuryo, and AlfredPay. This network provides Solv with immediate access to one of the world’s most extensive stablecoin distribution channels, accelerating the adoption of new yield functionalities.

According to Raja Chakravorti, Chief Business Officer of the Stellar Development Foundation:

Stellar: the blockchain for financial services

The Stellar network stands out for being decentralized, fast, scalable, and sustainable, with a structure designed to keep fees low and ensure transaction speed even as adoption increases. Since its launch, Stellar has processed billions of operations for millions of accounts, becoming a benchmark for asset issuance and payment settlement on a global scale.

Today, Stellar is a key player in the most active and rapidly growing payment corridors between the United States, Sub-Saharan Africa, Latin America, and Southeast Asia. With the expansion of cross-border transactions, retail users and businesses can now explore how daily remittances can transform into yield opportunities, linking cross-border payments with on-chain value accumulation mechanisms.

Solv Foundation: bridge between TradFi, CeFi, and DeFi

Solv Foundation positions itself as an on-chain reserve for Bitcoin, aiming to unlock the potential of over $1 trillion in Bitcoin assets through SolvBTC. Thanks to SolvBTC.LSTs (Liquid Staking Tokens), both retail and institutional investors can generate returns on their Bitcoin, transforming them from inactive assets into yield-generating instruments. The Solv protocol is backed by leading investors such as Binance Labs, Blockchain Capital, Laser Digital, and OKX Ventures.

New Prospects for DeFi on Stellar

The integration of Solv Foundation on Stellar marks a crucial step in the evolution of DeFi on this blockchain. Users will be able to leverage advanced yield strategies, while institutions will gain access to more sophisticated lending and capital management tools. This synergy between Solv and Stellar not only expands the use cases for USDC but also helps strengthen the digital financial ecosystem, making it more accessible, efficient, and productive.

Market Opportunity
Solv Protocol Logo
Solv Protocol Price(SOLV)
$0.004507
$0.004507$0.004507
-0.35%
USD
Solv Protocol (SOLV) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03